Clinical Trial

Chinese PE Multimodality Imaging Artificial Intelligence Study

Recruiting
View on ClinicalTrials.gov →
Summary
The CHinese pulmOnary Embolism Multimodality Imaging-artifiCial intelligencE Study (CHOICE) is a prospective observational multi-center study that will collect imaging text data and raw data of patients with pulmonary embolism (PE) in China. By combining artificial intelligence technology, it aims to identify imaging markers to assist in early diagnosis, differential diagnosis, risk stratification, and prognosis assessment of PE.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-07-28; most recent amendment 2024-08-27.
Trial Details
NCT Number NCT06526468
Lead Sponsor China-Japan Friendship Hospital
Conditions Pulmonary Embolism, Chronic Thromboembolic Pulmonary Hypertension, Chronic Thromboembolic Pulmonary Disease
Enrollment 1,500 participants
Start Date 2010-09-01
Primary Completion 2027-09-01 (estimated)
Study Completion 2028-09-01 (estimated)
Updated on ClinicalTrials.gov 2024-08-28